MedTrace Logo

Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?

NCT02310854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-04-22

No results posted yet for this study

Summary

To investigate the hypothesis that suture repair of a ruptured vkb, combined with a dynamic intraligamentary stabilization and microfracture of the femoral notch, results in at least equal effectiveness compared with an ACL reconstruction using autologous hamstring in terms of functional recovery one year postoperatively in terms of a patient self-reported outcome related to be able to conduct daily and sporting activities. Secondary, the evaluation of clinical outcomes, self-reported by the patient outcomes, osteoarthritis, rehabilitation time required for return to daily and sporting activities and levels of sporting activity which has returned in patients with status after an ACL rupture and suture repair augmented with a dynamic intraligamentary microfracture and stabilization of the femoral notch in comparison with an anterior cruciate ligament reconstruction with the ipsilateral hamstring graft.

Conditions

  • Anterior Cruciate Ligament Injury

Interventions

PROCEDURE

ACL Repair

augmented suture of acute ACL rupture (\<3 weeks after injury)

PROCEDURE

ACL reconstruction

reconstruction hamstring autograft

Sponsors & Collaborators

  • Orthopedisch Centrum Oost Nederland

    lead OTHER

Principal Investigators

  • R.A.G Hoogeslag, MD · OCON

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2026-04-30
Completion
2026-04-17

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02310854 on ClinicalTrials.gov